Acceptability of the NuvaRing Among College and Graduate Students (ACCEPT)

NCT00635570 Phase 4 COMPLETED Results posted

The ACCEPT study is a Phase IV trial in which women are randomized to either the NuvaRing® vaginal contraceptive ring or a low dose oral contraceptive to assess compliance, side effects, overall acceptability and intent to continue use of the method. The study is focused on the acceptability of the vaginal ring among female undergraduate or graduate students.

Details

Lead sponsor	University of Chicago
Phase	Phase 4
Status	COMPLETED
Enrolment	273
Start date	2008-07
Completion	2009-07

Conditions

• Birth Control Compliance

Interventions

• Ortho Tri-cyclen Lo
• NuvaRing

Primary outcomes

• Adherence Rate (Rate of Perfect Method Use) — For the first 3 months
  "Perfect use" was defined as reporting never missing a pill or never removing the contraceptive vaginal ring for more than 2 hours during days 1-21 of all three monthly cycles

Countries

United States